These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 2167632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Current results of chemotherapy in non-small cell lung cancer].
    Fukuoka M, Negoro S, Takada M, Matsui K, Takifuji N, Masuda N, Kawahara M, Furuse K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):203-9. PubMed ID: 2162439
    [Abstract] [Full Text] [Related]

  • 6. [An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
    Haneda H, Koizumi M, Hayashi T.
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):227-31. PubMed ID: 10700892
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
    Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tominaga K, Sakurai M, Suga J, Miyaoka H, Sano T, Keicho N.
    Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
    [Abstract] [Full Text] [Related]

  • 8. [Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology].
    Kleisbauer JP, Thomas P, Perol M, Taytard A, Poirier R, Collus MJ, Guerin JC, Vergnenegre A, Balmes P, Carles P.
    Rev Mal Respir; 1993 Aug; 10(4):307-12. PubMed ID: 7694331
    [Abstract] [Full Text] [Related]

  • 9. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M, Kiura K, Okabe K, Toki H, Kimura M.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
    Ishihara Y, Ichiwata T, Kuramitsu K, Yoneda S, Yamamoto M, Takizawa T, Ogata T, Uchiyama T, Yoshida K.
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1013-20. PubMed ID: 9644316
    [Abstract] [Full Text] [Related]

  • 12. European experience with ifosfamide in non-small cell lung cancer.
    Drings P.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
    Recchia F, Sica G, De Filippis S, Rea S, Frati L.
    Anticancer Res; 1997 Feb; 17(5B):3761-5. PubMed ID: 9427776
    [Abstract] [Full Text] [Related]

  • 16. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Feb; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 17. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H.
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [Abstract] [Full Text] [Related]

  • 18. [Cisplatin, doxorubicin and vindesine in the treatment of advanced non-small cell lung cancer].
    Akiyama J, Sato A, Honda K, Chida K, Watanabe T, Okano H, Okano A, Taniguchi M, Genma H, Aoki H.
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):419-24. PubMed ID: 1848420
    [Abstract] [Full Text] [Related]

  • 19. [Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
    Itami S, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Fukutani H, Tabata M, Hirano A, Mizunuma N, Nakagawa K.
    Gan To Kagaku Ryoho; 1990 May; 17(5):1015-20. PubMed ID: 2159265
    [Abstract] [Full Text] [Related]

  • 20. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J.
    Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.